Chinese Cohort Study of Chronic Kidney Disease

Summary

This study aimed to explore underlying mechanisms of chronic kidney disease progression and its association with adverse consequences. It will enroll approximately 5000 pre-dialysis chronic kidney disease patients aged between 18 and 74 years in mainland China and follow-up for at least 5 years. Questionnaires, anthropometric measures, laboratory tests, and biomaterials will be collected at baseline and annually. The principal clinical outcomes of the study consist of renal disease events, cardiovascular events, and death.

Conditions

• Renal Insufficiency, Chronic

Interventions

OTHER

Demographic factors, biomedical measurements, drugs used for controlling metabolic disorders, etc

Sponsors & Collaborators

• Peking University Third Hospital

  collaborator OTHER

• Dongzhimen Hospital, Beijing

  collaborator OTHER

• Beijing Hospital

  collaborator OTHER_GOV

• Beijing Boai Hospital

  collaborator OTHER

• Peking University Shenzhen Hospital

  collaborator OTHER

• First Affiliated Hospital of Guangxi Medical University

  collaborator OTHER

• Guizhou Provincial People's Hospital

  collaborator OTHER

• First Affiliated Hospital of Chengdu Medical College

  collaborator OTHER

• Affiliated Hospital of Hebei University

  collaborator OTHER

• The Second Hospital of Hebei Medical University

  collaborator OTHER

• The First Affiliated Hospital of Zhengzhou University

  collaborator OTHER

• the Affiliated Hospital of Hubei Traditional Chinese Medical College

  collaborator UNKNOWN

• Xiangya Hospital of Central South University

  collaborator OTHER

• The First Affiliated Hospital with Nanjing Medical University

  collaborator OTHER

• The First Affiliated Hospital of Dalian Medical University

  collaborator OTHER

• Chifeng Second Hospital

  collaborator UNKNOWN

• The First Affiliated Hospital of BaoTou Medical College

  collaborator OTHER

• Qilu Hospital of Shandong University

  collaborator OTHER

• Shandong Provincial Hospital

  collaborator OTHER_GOV

• Qianfoshan Hospital

  collaborator OTHER

• Second Hospital of Shanxi Medical University

  collaborator OTHER

• Minhang Central Hospital

  collaborator UNKNOWN

• West China Hospital

  collaborator OTHER

• Sichuan Provincial People's Hospital

  collaborator OTHER

• Tianjin Medical University General Hospital

  collaborator OTHER

• Tianjin Medical University Second Hospital

  collaborator OTHER

• the First Affiliated Hospital of the Medical College of Shihezi University

  collaborator UNKNOWN

• First Affiliated Hospital of Xinjiang Medical University

  collaborator OTHER

• The Second Affiliated Hospital of Kunming Medical University

  collaborator OTHER

• Yuxi City People's Hospital

  collaborator UNKNOWN

• Zhejiang University

  collaborator OTHER

• Xinqiao Hospital of Chongqing

  collaborator OTHER

• The Second Affiliated Hospital of Chongqing Medical University

  collaborator OTHER

• First Affiliated Hospital of Chongqing Medical University

  collaborator OTHER

• The Second Hospital of Anhui Medical University

  collaborator OTHER

• The First Affiliated Hospital of Anhui Medical University

  collaborator OTHER

• General Hospital of Ningxia Medical University

  collaborator OTHER

• Shengjing Hospital

  collaborator OTHER

• Peking University First Hospital

  lead OTHER

Principal Investigators

• Minghui Zhao, MD, Ph.D. · Peking University First Hospital

Eligibility

Min Age

18 Years

Max Age

74 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2012-01-01

Primary Completion

2026-12-31

Completion

2026-12-31

Countries

• China

Study Locations